MCM
BMY.RT
McRae Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-100,892
| Closed | -$70K | – | 109 |
|
|
2020
Q4 | $70K | Sell |
100,892
-425
| -0.4% | -$295 | 0.02% | 101 |
|
|
2020
Q3 | $228K | Buy |
101,317
+100
| +0.1% | +$225 | 0.08% | 86 |
|
|
2020
Q2 | $362K | Sell |
101,217
-100
| -0.1% | -$358 | 0.14% | 65 |
|
|
2020
Q1 | $385K | Buy |
101,317
+200
| +0.2% | +$760 | 0.19% | 60 |
|
|
2019
Q4 | $304K | Buy |
+101,117
| New | +$304K | 0.11% | 73 |
|